A potential new medicine for severe asthma the #NIMBLE Study
We will shortly be commencing recruitment into a new asthma trial sponsored by GlaxoSmithKline (GSK) called NIMBLE. A 52-week,...
A potential new medicine for severe asthma the #NIMBLE Study
Post Covid-19 research #Dynamo study at NIHR Nottingham BRC featured on BBC News
Patient Story Videos Part 4 - After the Trial
Study to assess remote monitoring of patients with an interstitial lung disease
The COMPAIR Study; A Comparison of Clinic-based Versus Home-based Spirometry
PRISM: Molecular phenotyping of severe asthma patients to determine response to biologic therapies
CF STORM a ground-breaking trial to assess management of CF patients daily healthcare routines
More positive results from #ANDHI study for Benralizumab in Severe Eosinophilic Asthma